Alyssa Shannon
Pediatrics Residency · Rutgers Health
Credentials: ·
History
- 2024–Present
Research
Phase 1 Clinical Trial of Trametinib and Ponatinib in Patients With NSCLC Harboring KRAS Mutations
JTO Clinical and Research Reports · 2022 · 10 citations
1 paper
1 paper
- GR
1 paper
- HY
1 paper
- KA
1 paper
- ML
1 paper
- MK
1 paper
- MB
1 paper
